Células hepáticas NoSpin HepaRG, 8 millones de céls.

Triangle Research Labs, LLC and Biopredic International have completed an agreement for TRL to distribute the NoSpin HepaRGcells in North America. Then HepaRGrepresent an important improvement over the original cryopreserved HepaRGcells. HepaRGis a fully-functional, adult-phenotype, human hepatic cell line. The HepaRGexhibits many characteristics similar to primary human hepatocytes and can be used for many of the same applications. Then HepaRGis provided in a convenient, terminally differentiated, cryopreserved format that does not require the user to centrifuge, resuspend, or count the cells after thawing. Each lot has consistent yield, viability, and functionality across multiple applications. The cells have been the subject of dozens of recent scientific papers and posters, demonstrating their suitability for all in-vitro analyses for which the more variable and expensive cryopreserved primary human hepatocytes have been used. HepaRGutilize a proprietary cryopreservation process that leverages the consistency and predictability of HepaRG responses and their post-thaw viability (typically 93-98%) with novel techniques developed by Biopredic scientists. All other forms of cryopreserved hepatocytes require thawing, suspension, centrifugation, resuspension, and counting (to account for variability introduced) steps; the HepaRGsimply need to be thawed and then they are ready for use. Not only will this benefit high-volume labs which now undertake many laborious and expensive steps to use hepatocytes, but all labs will gain from this format which reduces the risk of errors or variability.